loading

Immunoprecise Antibodies Ltd Borsa (IPA) Ultime notizie

pulisher
01:49 AM

HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World

01:49 AM
pulisher
Apr 02, 2025

ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia

Mar 31, 2025
pulisher
Mar 30, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo Finance

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) - Yahoo Finance

Mar 29, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies Reports Q3 FY25 Financial Results - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - 01Net

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies Ltd reports results for the quarter ended January 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

IMMUNOPRECISE ANTIBODIES Earnings Results: $IPA Reports Quarterly Earnings - Nasdaq

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Secures Game-Changing $10M Deal as AI Division Reports 132% Growth - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast - Benzinga

Mar 27, 2025
pulisher
Mar 26, 2025

IMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 26, 2025
pulisher
Mar 21, 2025

ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 17, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

What's Going On With ImmunoPrecise Stock Thursday?ImmunoPrecise Antibodies (NASDAQ:IPA) - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net

Mar 13, 2025
pulisher
Mar 13, 2025

Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments -March 13, 2025 at 07:55 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Partners for $10M Cancer Therapeutics Development - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025 - 01Net

Mar 12, 2025
pulisher
Mar 11, 2025

ImmunoPrecise Q3 Earnings Postponed: Auditors Request Extra Time for Goodwill Review - StockTitan

Mar 11, 2025
pulisher
Mar 11, 2025

ImmunoPrecise Antibodies Reschedules Q3 Financial Results Release - TipRanks

Mar 11, 2025
pulisher
Mar 06, 2025

ImmunoPrecise Antibodies (IPA) to Release Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ACCESS Newswire

Mar 05, 2025
pulisher
Mar 05, 2025

ImmunoPrecise Antibodies to Announce Q3 Fiscal 2025 Results - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

AI Antibody Pioneer ImmunoPrecise Sets March 13 Earnings CallWhat's Next for This Biotech Innovator? - StockTitan

Mar 05, 2025
pulisher
Mar 05, 2025

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 13, 2025 - Yahoo Finance

Mar 05, 2025
pulisher
Feb 27, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Expands AI Leadership with Dr. Kamil Isaev Appointment - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

IPA and Ribopro form mRNA antibody discovery collaboration - Yahoo Finance

Feb 27, 2025
pulisher
Feb 26, 2025

ImmunoPrecise Antibodies appoints Joseph Scheffler interim CFO - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

IPA and RIBOPRO Partner to Advance mRNA-Driven Antibody Discovery, Unlocking New Frontiers in Immunotherapy - 01Net

Feb 26, 2025
pulisher
Feb 26, 2025

ImmunoPrecise & RIBOPRO Partner for AI-Powered Antibody Discovery - Contract Pharma

Feb 26, 2025
pulisher
Feb 26, 2025

ImmunoPrecise Antibodies and RIBOPRO Partner to Revolutionize Antibody Discovery - TipRanks

Feb 26, 2025
pulisher
Feb 24, 2025

ImmunoPrecise Antibodies annonce un remaniement de son équipe de direction - The Hastings Tribune

Feb 24, 2025
pulisher
Feb 24, 2025

ImmunoPrecise Antibodies Announces Key Leadership Changes - Voice Of Alexandria

Feb 24, 2025
pulisher
Feb 24, 2025

AI Pioneer Joins ImmunoPrecise Board: Can New Leadership Accelerate Biotech Innovation? - Stock Titan

Feb 24, 2025
pulisher
Feb 20, 2025

ImmunoPrecise Antibodies Transfers to Nasdaq Capital Market, Gains Extension - TipRanks

Feb 20, 2025
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Capitalizzazione:     |  Volume (24 ore):